Where does Retrieve Medical, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Retrieve Medical, Inc. ranks #20,322 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Retrieve Medical, Inc. hold?

Retrieve Medical, Inc. holds 14 US utility patents granted between 2021 and 2025, spanning 4 technology areas.

What is Retrieve Medical, Inc.'s Innovation Score?

Retrieve Medical, Inc. has an Innovation Score of 43.3 out of 100 (top 28% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Retrieve Medical, Inc. focus on?

Retrieve Medical, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 11 patents, ranking #1,592 of 7,127 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

Is Retrieve Medical, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Retrieve Medical, Inc..

What does claim depth mean for Retrieve Medical, Inc.'s patents?

Retrieve Medical, Inc.'s patents average 11.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Retrieve Medical, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Retrieve Medical, Inc.

USPTO PatentsView assignee record - 14 granted patents across 4 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Retrieve ranks #20,322 of 49,997 tracked US assignees by granted-patent volume, with 14 patents across 4 technology areas.

#20,322
of 49,997 US assignees by volume: Top 28%
by Innovation Score (43.3/100): 11.5
avg claims per patent

USPTO PatentsView assignee plate

Corpus R20322 · US Corporation #20,322 · 14 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-PAR · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 14 grants
MID-PACK #20,322/49,997
PHOTO-FINISH Resense
CPC-NARROW A61B · 4 areas
INNOV-PAR 43.3/100
CLAIMS-PAR 11.5 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2021–2025 · 5y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Resense GmbH (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Retrieve’s 43.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.4 pts (22%) Velocity 20.0 pts (46%) Breadth 7.1 pts (16%) Claim depth 6.9 pts (16%)

Qualcomm Incorporated · highest

85
Retrieve Medical · this assignee

43
3D Lighting… · lowest

7

What this shows Retrieve's Innovation Score is 43.3/100 (top 28% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Retrieve?

Each dot is one of Retrieve’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Retrieve’s own 11.5 claims/patent is at or below the 15.3 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Retrieve vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Retrieve's grants concentrate

Retrieve Medical, Inc. is a focused PatentsView assignee: 4 CPC subclasses with 78.6% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2024 (5 grants) versus a trough of 1 in 2021. By volume, Retrieve sits between Resense GmbH and RevolutioNice Inc..

Retrieve's three-year grant acceleration

Retrieve Medical, Inc. shows 8 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Resense

14
Resnent

14
Resonance Technol…

14
Respicardia

14
Reveragen Biophar…

14
Revision Military

14
Revo Brand Group

14
Revolutionice

14
Retrieve Medical ◀

14

What this shows Retrieve holds 14 patents at rank #20,334, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Retrieve

By rank, the assignees closest to #20,334 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Retrieve's primary technology class.

Retrieve's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

43 Top 28% higher than 72% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table

Retrieve Medical, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2021	1	7.1%
2023	3	21.4%
2024	5	35.7%
2025partial year	5	35.7%

Which technologies does Retrieve Medical, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 11

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 11

G09B - Educational OR Demonstration APPLIANCES; Appliances FOR Teaching, OR Communicating With, THE Blind, Deaf OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; Diagrams 4

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 3

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Retrieve Medical, Inc.'s patent record in context - here's where to go next.

Retrieve Medical, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 78.6% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #20,322 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Retrieve Medical, Inc. against Resense GmbH, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 43.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.